CoQ10, another exogenous antioxidant reduced by FSP1, has shown limited clinical efficacy in NDDs.In a Phase III trial (NCT00740714), oral CoQ10 at 1200 or 2400 mg/day, combined with 1200 IU/day of vitamin E, did not slow PD progression, as UPDRS scores increased similarly across all groups (Beal et al., 2014)
Online providers often offer competitive pricing
Elle contribue la conversion efficace des graisses en nergie, ce qui en fait un complment populaire pour ceux qui s'entranent haute intensit
However, critical regulatory constraints significantly limit the contexts in which these peptides may be used
Some are research-grade peptides used in clinical settings, while others are low-dose, supplement-style capsules with little proven efficacy
This finding does not establish causality, but it is consistent with a model in which robust mitochondrial peptide signaling is a feature of successful aging rather than a peripheral correlate